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Bovine Colostrum Supplementation Optimises Earnings, Performance and 
Recovery in Racing Thoroughbreds 
Abstract 
Bovine colostrum (BC) is the first milk produced by cows after calving and contains numerous beneficial 
substances for the immunity and development of the newborn calf. Because of the growth and immune 
factors in BC, it has become an attractive supplement for use by athletes to support immunity and health 
during athletic performance. In order to evaluate the effects of oral BC supplementation on equine 
athletes, this study evaluated the earnings, performance, recovery and incidence of upper respiratory 
infections (URTI) in racing horses. The study design was a randomized cross-over racing performance 
study. 21 horses in race training were randomly assigned to train and compete with or without BC 
supplementation. After each horse competed in three races, it was crossed over to the other group, 
allowed a three week washout period, and then competed in three additional races. Horses in public 
training stables of 3 participating trainers were used. Race performance as determined by earnings, 
Bloodstock Research Information System (BRIS) speed figures, recovery as determined by number of 
days between races and incidence of upper respiratory tract disease was recorded. 11 horses completed 
the study. There was no effect of the order of BC supplementation on the measured variables. Horses on 
BC supplementation earned $ 2,088 more purse money per race, than when unsupplemented (P = 0.016), 
and ran an average of 5 BRIS speed points higher (P = 0.03). Horses returned to racing on average 7.5 
days faster (16.9 days vs 24.4 days, P = 0.048). There were no URTI among the horses on BC 
supplementation and two infections while not on BC supplementation (z-test, P = 0.11). Statistical 
analysis showed that horses recovered more quickly, earned three times more money and raced better as 
judged by BRIS scores while competing with BC supplementation. BC supplemented horses also 
experienced fewer URTI, although this effect was not significant. 
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1. Introduction
Bovine colostrum (BC) is the first milk produced by 
cows after calving. BC contains immunoglobulins, other 
immune factors, growth factors and nutrients necessary 
for optimal immunity, support and long term performance 
of the neonatal calf. More recently, BC has been used as a 
nutritional supplement in humans for both immune support 
and for optimising athletic performance. In humans, BC 
has been shown to be effective in reducing the incidence of 
influenza (Cesarone et al., 2007), and upper respiratory tract 
infections (URTI) in children (Patel and Rana, 2006), and 
in athletes (Brinkworth and Buckley, 2003). In humans, BC 
has been found to improve endurance cycling performance 
(Coombes et al., 2002) and to enhance recovery and improve 
performance following sequential exercise sessions (Buckley 
et al., 2002; Shing et al., 2006).
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Abstract
Bovine colostrum (BC) is the first milk produced by cows after calving and contains numerous beneficial substances 
for the immunity and development of the newborn calf. Because of the growth and immune factors in BC, it has 
become an attractive supplement for use by athletes to support immunity and health during athletic performance. 
In order to evaluate the effects of oral BC supplementation on equine athletes, this study evaluated the earnings, 
performance, recovery and incidence of upper respiratory infections (URTI) in racing horses. The study design was 
a randomized cross-over racing performance study. 21 horses in race training were randomly assigned to train and 
compete with or without BC supplementation. After each horse competed in three races, it was crossed over to the 
other group, allowed a three week washout period, and then competed in three additional races. Horses in public 
training stables of 3 participating trainers were used. Race performance as determined by earnings, Bloodstock 
Research Information System (BRIS) speed figures, recovery as determined by number of days between races and 
incidence of upper respiratory tract disease was recorded. 11 horses completed the study. There was no effect of 
the order of BC supplementation on the measured variables. Horses on BC supplementation earned $ 2,088 more 
purse money per race, than when unsupplemented (P=0.016), and ran an average of 5 BRIS speed points higher 
(P=0.03). Horses returned to racing on average 7.5 days faster (16.9 days vs 24.4 days, P=0.048). There were no URTI 
among the horses on BC supplementation and two infections while not on BC supplementation (z-test, P=0.11). 
Statistical analysis showed that horses recovered more quickly, earned three times more money and raced better 
as judged by BRIS scores while competing with BC supplementation. BC supplemented horses also experienced 
fewer URTI, although this effect was not significant.
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Horse racing is a highly competitive sport in which trainers 
and veterinarians strive to maintain their animals in 
optimal health. Dietary supplements that support immune 
responses and thereby optimise the health, welfare and 
athletic performance of horses are potentially of great 
benefit to the racing industry. While the effect of BC dietary 
supplementation may be related to reported increases in 
plasma immunoglobulin (IGF)-1 in humans (Mero et al., 
1997), no such BC supplementation increases in IGF-1 
occurs in horses associated with the BC supplementation 
protocol reported herein (Fenger et al., 2014).
Given these considerations, this study was undertaken to 
determine if BC has a beneficial effect on the incidence 
of URTI and athletic performance in Thoroughbred 
racehorses.
2. Materials and methods
Study facilities and animals
Privately owned Thoroughbred racehorses in race training 
in Central Kentucky were used throughout. Horses were 
housed and trained according to standard racing stable 
management procedures at a Thoroughbred training facility 
in Lexington, KY, USA. Horses were stabled in 3.7×3.7 
m stalls bedded in straw. Training consisted of trotting 
approximately 1.6 to 2.4 km (1 to 1.5 miles) and galloping 
approximately 1.6 to 2.4 km (1 to 1.5 miles) either on the dirt 
racetrack or a turf exercise field five days a week, with about 
one breezing day (fast gallop approaching racing speeds 
for 0.6 to 1.0 km (3/8 to 5/8 mile) per week and one day of 
walking only per week. Races were chosen according to the 
standard operating procedures of the 3 trainers involved. 
The study protocol was approved by the institutional animal 
care and use committee of Equine Integrated Medicine PLC 
and for all horses participating in the study, the owner or his 
or her designee (i.e. the trainer) provided informed consent.
Bovine colostrum
The colostrum used in this trial was produced under USDA 
and CFIA permits for commercial sale as a veterinary 
biologic. Excess colostrum was collected from dairies 
licensed to produce milk for human consumption and 
stored frozen (-18 °C) until processing. The colostrum was 
then thawed at room temperature until softened sufficiently 
to be pooled following pulverisation by an ice crusher, 
then pasteurised using a proprietary method (Saskatoon 
Colostrum Company, Ltd., Sasketchewan, Canada) 
developed to eliminate pathogenic contaminants while 
maintaining the integrity of the immune factors and spray 
dried. The spray dried colostrum was tested for retention 
of potency using an radial immunodiffusion method for 
IgG and for safety using standard microbiological methods 
for total plate counts, coliforms and Salmonella. The BC 
powder was then packaged by Animal Healthcare Products 
and Packaging, Inc. (Winchester, KY, USA) according 
to good manufacturing practices protocol before being 
shipped to the study location.
Experimental design
All racehorses in the three participating trainers’ control 
were included in this cross-over study. Trainers were 
previously known to one of the investigators (CF) to be 
reliable and able to comply with the study procedures. 
Horses were randomly assigned to the BC supplementation 
first or no BC supplementation first groups. Horses in the 
treatment group received 100 g BC daily as a feed top dress 
for at least weeks prior to the first race and until 3 races 
were completed, at which point they had a 3 week washout 
period, followed by three races without BC supplement. 
Horses in the no BC supplementation first group had three 
races, followed by at least a 3 week acclimation period on 
100 g BC daily, which period continued until 3 races were 
completed. Horses which were claimed, sold or retired prior 
to completing the 6 race regimen were excluded from the 
performance data analysis. All horses were included in the 
URTI incidence data. Horses that completed the study were 
all 3 or 4 year olds, with 3 geldings, a male and 2 females in 
the no-treatment first group and four females and a gelding 
in the treatment first group.
Because of the differences in racing class, time of year, track 
surface and condition, the times or finish positions of the 
races were not considered to be useful for analysis. Racing 
performance was analysed based on the BRIS speed figure 
for each race; Bloodstock Research Information System 
(BRIS) speed figures were generated by an independent 
organisation (Bloodstock research Information System, 
Lexington, KY, USA; www.brisnet.com) and recorded for 
each of the six races for each horse. This standardised 
number represents a racing score independent of other 
factors. The amount of money earned for each race was 
similarly recorded. The total amount of money earned was 
averaged for each horse for the three races in each group. 
Recovery days between races were similarly averaged for 
all BC days and all non-BC days for each horse. Layoffs 
associated with injuries were excluded from the recovery 
data. Upper respiratory tract infections were defined as 
a nasal discharge and cough, which was diagnosed by 
endoscopy to be due to either lymphoid hyperplasia or 
guttural pouch infection.
Data analysis
The analysis of variance for a cross-over design, controlling 
for period, sequence, and horse, was fit to the data. 
Normality in each of the independent variables was 
determined by visual inspection of normality plots and 
Anderson-Darling test of normality, and analysed using a 
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general linear model (Proc GLM; SAS Institute, Cary, NC, 
USA). When normality assumptions were not fulfilled, the 
data were transformed before analysis to appropriately meet 
model assumptions. Normality assumptions were met for 
the analysis of average BRIS speed figures, money earned 
in the treatment and control races, and for the square root 
transformed recovery days. F-tests were used to determine 
the presence of carryover and sequence effects. Incidence 
of URTI was analysed using a z-test.
3. Results
A total of 21 racehorses were originally enrolled in the 
study, with 11 horses completing the study. Seven horses 
were sold before completing 6 races and 3 were 2 year 
olds which never started during the study period. Because 
the horse sales and 2 year olds were independent of the 
assigned treatment, the 10 horses not contained in the 
analysis are considered missing at random and hence are 
unlikely to unduly bias the results presented here. Of the 
11 horses completing the study, 2 horses were excluded 
from the recovery analysis owing to injuries, which affected 
the days off between races. An ex-post power study was 
performed on the cross-over design used to analyse these 
data. Across all response variables, a maximum of 10 
horses was necessary for least 80% power, hence the 11 
horses considered in this study is sufficient for average 
horse effects. Further studies, using a greater number of 
horses, would be required to find different effects of bovine 
colostrum across genders. However, gender stratification 
is shown in the figures to demonstrate that there appears 
to be no difference between genders.
A standard linear, normal model was fit to the data using 
the appropriate analysis of variance model for a cross-over 
design, controlling for period, sequence, and horse. For each 
response variable we investigated departures from normality 
with both visual inspections and an Anderson-Darling test 
of normality. Neither earnings nor BRIS numbers deviated 
from the assumption of normality, however, Recovery (days 
between races) failed the normality test, so a square root 
transformation was performed before analysis. No response 
variable showed a sequence effect (earnings, P=0.48; BRIS 
numbers, P=0.12; recovery, P=0.33) or carry-over effect 
(earnings, P=0.16; BRIS numbers, P=0.53; recovery, P=0.24), 
thus suggesting our cross-over model is not inappropriately 
fit to these data. Earnings were higher (P=0.016) with least 
squares means of $ 3,241 for horses while receiving BC 
supplementation compared to $ 1,153 for horses while not 
on BC (Figure 1). The data also show an improvement in 
speed (BRIS number, P=0.03) with horses running a least 
squares mean of 67 while racing on BC and 62 when not 
on BC (Figure 2). Horses also returned to racing 7.5 days 
quicker (16.9 days vs 24.4 days, P=0.048) while supplemented 
with BC (Figure 3). In this study, no statistically significant 
effect of BC supplementation could be identified on the 
incidence of URTI (P=0.11), likely because of the small 
number of test animals and the relatively small incidence 
of overt URTI in this cohort.
4. Discussion
Our data demonstrated a clear improvement in athletic 
performance in horses receiving BC supplementation. 
Horses raced faster (higher BRIS speed figures) with 
0
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Figure 1. Average race earnings (US$, P=0.016) for all horses 
with or without bovine colostrum (BC) supplementation 
(randomly jittered along the x-axis for clarity). The horizontal 
bars across each treatment represents the least squares mean 
as predicted by the model fit to the data shown.
Treatment
BR
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no BC BC
Filly
Gelding
Male80
60
40
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0
Figure 2. Average BRIS speed ratings (P=0.03) for all horses with 
or without bovine colostrum (BC) supplementation (randomly 
jittered along the x-axis for clarity). The horizontal bars across 
each treatment represents the least squares mean as predicted 
by the model fit to the data shown.
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aggregate greater earnings of $ 70,455 over the course 
of this study while supplemented with BC. BRIS speed 
figures are calculated based on a computed algorithm 
which takes into account racetrack, surface, track condition, 
quality of the other horses in the race, and other factors 
contributing to the racing performance of a horse in a given 
day (www.brisnet.com). This is a performance metric which 
is comparable across all races on all days and is computed 
for all horses in North America. BRIS speed figures translate 
into approximately 1 point per 1-1.5 lengths in a race, 
with the value of a length decreasing as the race distance 
increases to accurately reflect racing effort. Therefore, the 
5 BRIS speed figure improvement in racing performance in 
horses on BC supplementation reflects an approximately 
5 length improvement in racing performance.
The performance effects of dietary supplementation 
with BC in human athletes is mixed. No improvement 
in performance was seen in a small double-blind study in 
healthy men and women undergoing aerobic and resistance 
training (Antonio et al., 2001), although there was an 
increase in lean body mass. Similarly, no performance 
effect was seen in endurance exercise in male and female 
hockey players (Hofman et al., 2002), rowing ability in 
elite female rowers (Brinkworth et al., 2002), or a single 
exercise-to-exhaustion test (Buckley et al., 2002). On the 
other hand, a small improvement in a 2 h endurance time 
trial in cyclists after an 8-week supplementation period has 
been reported (Coombes et al., 2002), and a recent study 
found increased leg press strength when older adults were 
supplemented with BC (Duff et al., 2014).
The mechanism of athletic performance improvement in 
humans has not been determined, but has been suggested to 
be associated with an increase in serum IGF-1 concentration 
(Mero et al., 1997). However, the magnitude of the increase 
of IGF-1 seen in the Mero study was small, did not exceed 
the normal range, and has not been repeatable by other 
investigators (Buckley et al., 2002; Coombes et al., 2002; 
Duff et al., 2014). Similarly to these latter studies, there 
is no increase in IGF-1 in Thoroughbred race horses 
associated with BC supplementation (Fenger et al., 2014). 
This indicates that any improvement in performance seen 
with BC in these horses was independent of an IGF-1 effect.
One possible mechanism could be related to other cytokines 
in BC, such as interleukin (IL)-1β, IL-6, tumour necrosis 
factor alpha (TNF-α), interferon-gamma (INF-γ) and IL-1 
receptor antagonist (IL-1ra), any of which may have an 
effect on athletic performance. While most cytokines would 
typically be degraded in the digestive tract, it has been 
suggested that cytokines in BC may be protected by some 
unidentified mechanism, resulting in their survival through 
the digestive process and absorption into the circulation 
(Davison, 2012). The role of inflammatory cytokines, such 
as IL-1β, IFN-γ, IL-6 and TNF-α during exercise is to send 
critical signals to exercising muscles that reactive oxygen 
species and other indicators of stress are forthcoming. 
These critical signals set off a cascade of reactions mediated 
by nuclear factor kappa-beta (NF-κβ), which moderates 
adaptation to exercise (Radak et al., 2013). If these cytokines 
are absorbed from the BC, then this adaptation may be the 
mechanism of the improved performance during exercise.
Post-exercise recovery was improved with BC 
supplementation in our subjects. Horses were able to race 
back 7.5 days quicker, reflecting a shorter recovery time after 
a maximal racing effort in our study. This is a similar finding 
to studies in humans. In an 8-week, double-blinded, placebo-
controlled study, BC supplementation did not improve 
performance on an exercise-to-exhaustion test. However, 
it did improve performance on a repeat test 20 min later 
(Buckley et al., 2002). In cyclists performing high intensity 
exercise tests with short recovery times, BC supplementation 
also benefitted recovery (Shing et al., 2006). The improved 
recovery may be the result of a reduction in oxidative stress 
in skeletal muscle during exercise while supplemented with 
BC (Appukutty et al., 2013).
In our study, there was no difference in incidence of overt 
URTI in horses while BC supplemented. However, this 
was likely due to an overall low rate of overt URTI in this 
cohort. In humans, BC supplementation decreased the 
incidence of influenza (Cesarone et al., 2007), URTI in 
Treatment
no BC BC
Filly
Gelding
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Re
co
ve
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50
40
30
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Figure 3. Average recovery days between races for the 
second and third races with or without bovine colostrum (BC) 
supplementation for all horses (randomly jittered along the 
x-axis for clarity). The horizontal bars across each treatment 
represents the least squares mean as predicted by the model 
fit to the data shown. Two horses were excluded from analysis 
because of illness or injury. Statistical analysis was performed 
on transformed data (P=0.048), but non-transformed data are 
shown here.
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children (Patel and Rana, 2006), and in athletes (Brinkworth 
and Buckley, 2003). Intense exercise training is well known 
to cause immunosuppression in humans (Smith, 2003) and 
horses (Davis et al., 2007) which can manifest as URTI. This 
has been suggested to result from a suppression of TH-2 
cell-mediated immunity by an exercise related increase 
in the TH-1 immune response (Smith, 2003), and an 
increase in natural killer (NK) cells (Wong et al., 2014). In 
human studies, BC supplementation has multiple immune 
system effects in athletes, including increasing salivary 
immunoglobulin A concentrations in runners (Crooks et al., 
2006), improvement in the recovery of neutrophil function 
and maintenance of salivary lysozyme concentrations in 
cyclists (Davison and Diment, 2010), and preventing the 
TH-2 immune suppression associated with exercise in 
cyclists (Shing et al., 2007). While our URTI data did not 
attain statistical significance, the overall incidence of overt 
URTI was low in our group. This was likely the result of the 
requirement of the crossover model for 6 or 7 sequential 
races. Often, younger horses, which are more susceptible to 
overt URTI, fail to make this number of races sequentially 
without substantial layoffs. Nonetheless, the only overt 
URTI were in the horses during the non-BC supplemented 
period, and it is likely that subclinical infection also occurs, 
which may have detrimental performance effects. The 
mechanism of decreased incidence of URTI in athletes 
supplemented with BC is likely associated with an immune 
modifying effect of the BC supplementation, presumably 
offsetting the transient immunosuppression associated with 
intense exercise. An immune modifying effect may have 
influenced performance and recovery in this study, although 
this cannot be unequivocally shown with these data.
The horse is physiologically unique in that as soon as it 
begins to exercise it fails to fully oxygenate its blood (Fenger 
et al., 2000), suffering from ‘exercise induced hypoxemia’. 
The stroke volume of blood travels so rapidly across the 
pulmonary circulation that there is insufficient time for 
complete oxygenation across the thin alveolar-capillary 
membrane. Inflammation in the airways as may be caused 
by subclinical infection acts to exacerbate ‘exercise induced 
hypoxemia’ in horses, by thickening this alveolar-capillary 
membrane. Demonstrating this phenomenon, Sánchez et 
al. (2005) showed that the faster a horse runs the greater 
the oxygen deficit in the blood delivered to the muscles, 
and that this deficit is exacerbated by airway inflammation. 
Any intervention that reduces airway inflammation may 
be expected to immediately and proportionally improve 
oxygen delivery to the exercising musculature and thus 
equivalently improve racing performance, and may have 
been the mechanism of the performance benefit seen in 
the present study.
In conclusion, BC can be supplemented to racehorses 
for the purpose of optimising athletic performance and 
recovery of the animal. Further studies to elucidate the 
optimal dose, extent and specific mechanisms of immune 
modifying effect of BC in exercising horses are warranted.
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